Structural basis for lack of toxicity of the diphtheria toxin mutant CRM197
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
CRM197 is an enzymatically inactive and nontoxic form of diphtheria toxin that contains a single amino acid substitution (G52E). Being naturally nontoxic, CRM197 is an ideal carrier protein for conjugate vaccines against encapsulated bacteria and is currently used to vaccinate children globally against Haemophilus influenzae , pneumococcus, and meningococcus. To understand the molecular basis for lack of toxicity in CRM197, we determined the crystal structures of the full-length nucleotide-free CRM197 and of CRM197 in complex with the NAD hydrolysis product nicotinamide (NCA), both at 2.0-Å resolution. The structures show for the first time that the overall fold of CRM197 and DT are nearly identical and that the striking functional difference between the two proteins can be explained by a flexible active-site loop that covers the NAD binding pocket. We present the molecular basis for the increased flexibility of the active-site loop in CRM197 as unveiled by molecular dynamics simulations. These structural insights, combined with surface plasmon resonance, NAD hydrolysis, and differential scanning fluorimetry data, contribute to a comprehensive characterization of the vaccine carrier protein, CRM197.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
PHENIX : building new software for automated crystallographic structure determination
Adams, P. D., Grosse-Kunstleve, R. W., Hung, L.-W., Ioerger, T. R., McCoy, A. J., Moriarty, N. W., Read, R. J., Sacchettini, J. C., Sauter, N. K., & Terwilliger, T. C. (2002) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444902016657 · Cited by 4,361
The crystal structure of diphtheria toxin
Choe, S., Bennett, M. J., Fujii, G., Curmi, P. M. G., Kantardjieff, K. A., Collier, R. J., & Eisenberg, D. (1992) · Nature · doi:10.1038/357216a0 · Cited by 669 · cited 1×
“Nonetheless, the swapping of the R domains makes the assembled CT domains from one chain and the R domain from the second chain virtually identical to the monomeric “closed” DT reported previously (13) (Fig.”
BackgroundDomain swapping: entangling alliances between proteins.
Bennett, M. J., Choe, S., & Eisenberg, D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3127 · Cited by 532 · cited 1×
“S1), as observed previously in dimeric DT (23).”
BackgroundMaintaining protection against invasive bacteria with protein–polysaccharide conjugate vaccines
Pollard, A. J., Perrett, K. P., & Beverley, P. C. (2009) · Nature Reviews Immunology · doi:10.1038/nri2494 · Cited by 485
Collier, R. J. (2001) · Toxicon · doi:10.1016/s0041-0101(01)00165-9 · Cited by 318 · cited 1×
“This arose as an artifact of freezing the toxin in sodium phosphate (21, 22).”
BackgroundHadfield, T. L., McEvoy, P., Polotsky, Y., Tzinserling, V. A., & Yakovlev, A. A. (2000) · The Journal of Infectious Diseases · doi:10.1086/315551 · Cited by 266 · cited 1×
“Although diphtheria has now been virtually eliminated in the industrialized world, rare outbreaks still occur worldwide (1, 2).”
BackgroundThe amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197
Giannini, G., Rappuoli, R., & Ratti, G. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.10.4063 · Cited by 251
Self-citationHow Bacterial Carbohydrates Influence the Adaptive Immune System
Avci, F. Y., & Kasper, D. L. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101159 · Cited by 238
Crystal Structure of Diphtheria Toxin Bound to Nicotinamide Adenine Dinucleotide
Bell, C. E., & Eisenberg, D. (1996) · Biochemistry · doi:10.1021/bi9520848 · Cited by 198
Pappenheimer, A. M., & Gill, D. M. (1973) · Science · doi:10.1126/science.182.4110.353 · Cited by 180
Reconstitution of Diphtheria Toxin from Two Nontoxic Cross-Reacting Mutant Proteins
Uchida, T., Pappenheimer, A. M., & Harper, A. A. (1972) · Science · doi:10.1126/science.175.4024.901 · Cited by 176 · cited 2×
“no release of fragment A can take place upon addition of DTT alone; for this to happen, trypsin would also be required (24).”
BackgroundResultRefined structure of monomelic diphtheria toxin at 2.3 Å resolution
Bennett, M. J., & Eisenberg, D. (1994) · Protein Science · doi:10.1002/pro.5560030912 · Cited by 175
Refined structure of dimeric diphtheria toxin at 2.0 Å resolution
Bennett, M. J., Choe, S., & Eisenberg, D. (1994) · Protein Science · doi:10.1002/pro.5560030911 · Cited by 159
Carbohydrate—protein conjugate vaccines
Ada, G., & Isaacs, D. (2003) · Clinical Microbiology and Infection · doi:10.1046/j.1469-0691.2003.00530.x · Cited by 142
Overview of the development and current use of CRM197 conjugate vaccines for pediatric use
Shinefield, H. R. (2010) · Vaccine · doi:10.1016/j.vaccine.2010.04.072 · Cited by 123
Crystal Structure of the Complex of Diphtheria Toxin with an Extracellular Fragment of Its Receptor
Louie, G. V., Yang, W., Bowman, M. E., & Choe, S. (1997) · Molecular Cell · doi:10.1016/s1097-2765(00)80008-8 · Cited by 110
Crystal Structure of Diphtheria Toxin Bound to Nicotinamide Adenine Dinucleotide
Bell, C. E., & Eisenberg, D. S. (1997) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-8632-0_4 · Cited by 66 · cited 9×
“In DT, this loop is positioned over the NAD-binding pocket and is thought to be important for access of NAD to the binding cleft and for EF-2 recognition (16).”
BackgroundInfluentialDimeric form of diphtheria toxin: purification and characterization
Carroll, S. F., Barbieri, J. T., & Collier, R. J. (1986) · Biochemistry · doi:10.1021/bi00357a019 · Cited by 63 · cited 1×
“This arose as an artifact of freezing the toxin in sodium phosphate (21, 22).”
BackgroundBinding properties of diphtheria toxin to cells are altered by mutation in the fragment A domain.
Mekada, E., & Uchida, T. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38999-8 · Cited by 58 · cited 1×
“For example, CRM197 and DTwere shown to possess different susceptibilities to proteolysis (32); monoclonal antibodies against CRM197 showed different binding properties when compared with binding to DT (33); CRM197 was also shown to be less stable in the cytoplasm than DT (34); and ATP was shown to bind to DT inhibiti…”
BackgroundCrystal Structure of Nucleotide-Free Diphtheria Toxin,
Bell, C. E., & Eisenberg, D. S. (1997) · Biochemistry · doi:10.1021/bi962214s · Cited by 58 · cited 14×
“In summary, although NF-CRM197 has an overall fold virtually identical to NF-DT, one major difference is observed in the displacement of the active-site loop that covers the NADbinding pocket of DT. Structure of Nicotinamide-CRM197.”
BackgroundMethodInfluentialStructure of the Isolated Catalytic Domain of Diphtheria Toxin
Weiss, M. S., Blanke, S. R., Collier, R. J., & Eisenberg, D. S. (1995) · Biochemistry · doi:10.1021/bi00003a010 · Cited by 57
Kageyama, T., Ohishi, M., Miyamoto, S., Mizushima, H., Iwamoto, R., & Mekada, E. (2007) · The Journal of Biochemistry · doi:10.1093/jb/mvm116 · Cited by 54
Active-site mutations of diphtheria toxin. Tryptophan 50 is a major determinant of NAD affinity.
Wilson, B. A., Blanke, S. R., Reich, K. A., & Collier, R. J. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31653-8 · Cited by 35
Active-Site Mutations of Diphtheria Toxin: Role of Tyrosine-65 in NAD Binding and ADP-Ribosylation
Blanke, S. R., Huang, K., & Collier, R. J. (1994) · Biochemistry · doi:10.1021/bi00255a031 · Cited by 29 · cited 1×
“Y65 is essential for NAD binding (30), and as in NAD-DT, it forms an aromatic stacking interaction with the ring of NCA and Y54 (Fig.”
BackgroundConformational changes in diphtheria toxoids
Bigio, M., Rossi, R., Nucci, D., Antoni, G., Rappuoli, R., & Ratti, G. (1987) · FEBS Letters · doi:10.1016/0014-5793(87)81060-8 · Cited by 26
Self-citationCrystallization of diphtheria toxin
Fujii, G., Choe, S., Bennett, M. J., & Eisenberg, D. S. (1991) · Journal of Molecular Biology · doi:10.1016/0022-2836(91)90577-s · Cited by 13 · cited 1×
“protein in PBS buffer as previously reported for crystal forms III and IV of DT (20).”
Background
Cited by
Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases
Furtado, D., Björnmalm, M., Ayton, S., Bush, A. I., Kempe, K., & Caruso, F. (2018) · Advanced Materials · doi:10.1002/adma.201801362 · Cited by 708
Application of built-in adjuvants for epitope-based vaccines
Lei, Y., Zhao, F., Shao, J., Li, Y., Li, S., Chang, H., & Zhang, Y. (2019) · PeerJ · doi:10.7717/peerj.6185 · Cited by 115
“The function of DTT is to assist the enzyme active region (C-domain) in passing through the endocytosis membrane, and there are no associated risks when the transmembrane domain of DTT is used as the protein carrier for exogenous antigen (Ladokhin, 2013; Malito et al., 2012).”
BackgroundGuerreiro, A., Compañón, I., Lazaris, F. S., Labão‐Almeida, C., Oroz, P., Ghirardello, M., Marques, M. C., Corzana, F., & Bernardes, G. J. L. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202411009 · Cited by 28
Engineering intramolecular adjuvants for next-generation vaccines
Wang, Y., Liao, W., Zhang, Z., Wang, T., Zhang, J., Zai, X., & Xu, J. (2026) · The Innovation Medicine · doi:10.59717/j.xinn-med.2026.100258
Metadata
- Authors
- Malito, E., Bursulaya, B., Chen, C., Surdo, P. L., Picchianti, M., Balducci, E., Biancucci, M., Brock, A., Berti, F., Bottomley, M. J., Nissum, M., Costantino, P., Rappuoli, R., & Spraggon, G.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2012-03-19
- Volume
- 109
- Issue
- 14
- Pages
- 5229-5234
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W1997190724
- Cited by
- 158
- References
- 27
- FWCI
- 3.76
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.